Narayan Saraf

About Narayan Saraf

Finance professional with 25+ years of leadership across Pharma, FMCG, Healthcare and Energy sectors. An authentic leader known for strategic vision, resilience, and coaching finance talent embedding ethics and deliver enduring business value. Successfully led finance functions at ONGC, Hindustan Unilever, Cipla, Thermo Fisher, API-Pharmeasy, HRIPL and JB Pharma. Recognized for delivering sustainable growth, EBITDA improvement, and governance excellence while building high-performing, future-ready teams.4. Proven expertise in financial strategy, M&A, business partnering, investor relations, PE Exit, Governance (Audit, Risk and Compliance) and digital finance transformation across India and global markets. Extensive experience in managing Boards of both listed and private companies, delivering strategic insight, governance excellence, and stakeholder alignment at the highest level through Board Discussions, Audit Committee meetings, ERM and NRC.6. Adept at steering organizations through diverse life cycles—from PE-backed turnarounds to capital-rich industry leaders—aligning financial strategy with long-term business goals.

Experience

1. Chief Financial Officer

   Jb

   Feb 2024 — Present · Mumbai, IN

   Strategic Transactions & Growth Spearheaded one of India’s largest pharma strategic transactions (2nd largest ever in the industry), managing end-to-end Business, Finance, Tax & Legal due diligence, investor interactions, regulatory submissions and PE exit process. Partnered with bankers and consultants to design a comprehensive 5-year business and financial model, enabling promoters’ strategic stake sale and strengthening buyer confidence. Partnered with consultants and advisors for CCI approval, SEBI filings, and merger applications, ensuring accuracy and timeliness.2. Financial Performance & Transformation Delivered EBITDA growth of 16% and PAT growth of 19% YoY, while maintaining a robust balance sheet and healthy cash flow. Key FY25 Performance Metrics:Revenue: ₹3918 Cr (12% Growth), & Cash Flow from Operations: ₹903 Cr; Achieved ~₹40+ Cr savings vs budget, optimized working capital, paid all debts & improved tax efficiency. Accelerated monthly book closure from Day 5 to Day 2 across subsidiaries; enabled BU-wise MIS and reviews by Day 5 with higher accuracy.3. Governance, Compliance & Risk Management Strengthened governance through Board presentations, Audit Committee discussions, & Investor presentations, driving credibility and alignment. Ensured zero non-compliance in FY25; Enhanced risk management with robust RACM (no IFC deficiencies), timely closure of IA observations, & ERM updates to the Board, strengthened DOA & SOP frameworks. Reinforced compliance culture via UCPMP automation, hybrid compliance trainings (ABAC, POSH, UCPMP), and initiatives like “Compliance Carnival.”4. Functional & People Leadership Additional direct oversight of Legal, Company Secretary, and IT functions, enabling stronger governance, compliance, and digital transformation. Built a Future-Ready Finance Organization: filled critical vacancies, completed capability assessments,

Education

• Institute of Cost and Work Accountants of India

  ICWA

  1999 — 2003

• Harvard Business School Executive Education

  Advanced Management Program

• Insitute of Chartered Accountants of India

  CA

  1999 — 2005

• The Chartered Institute of Management Accountants

  CIMA Strategic Level

  2004 — 2007